Literature DB >> 6096727

Influence of neuronal uptake on the presynaptic alpha-adrenergic modulation of noradrenaline release.

M A Enero.   

Abstract

Conditions required for the inhibitory feedback modulation of noradrenergic neurotransmission were studied in isolated atria of the rat. The alpha adrenergic antagonist, yohimbine, 0.8 microM, or phentolamine, 1 microM, did not affect the chronotropic response to 4 or 8 shocks at 0.8 Hz but increased it when a higher number of shocks was applied. When neuronal uptake was inhibited by cocaine, 2.9 microM, or desipramine, 0.1 microM, the enhancement of neurotransmission by yohimbine or phentolamine was higher than that observed in the presence of alpha-adrenergic antagonists alone. In atria preincubated with 3H-noradrenaline, the effect of the drugs on the 3H-overflow evoked by 240 shocks at 2.0 Hz was studied. Cocaine 2.9 microM, did not increase the evoked overflow but yohimbine, 0.8 microM, did. The 3H-overflow obtained in the group of yohimbine plus cocaine was significantly higher than was expected from the effects of both drugs alone. It is concluded that yohimbine or phentolamine enhance the chronotropic response in rat atria only when the concentration of noradrenaline in the biophase is sufficiently high to activate presynaptic receptors. In this tissue, the efficiency of the neuronal uptake influences the degree of alpha-adrenergic autoinhibition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096727     DOI: 10.1007/bf00496103

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

2.  Physiological significance of alpha-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation.

Authors:  S Z Langer; E Adler-Graschinsky; O Giorgi
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

3.  Conditions required for the inhibitory feedback loop in noradrenergic transmission.

Authors:  D F Story; M W McCulloch; M J Rand; C A Standford-Starr
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

4.  Evidence against presynaptic alpha-adrenoreceptor modulation of cardiac sympathetic transmission.

Authors:  J A Angus; P I Korner
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

5.  An analysis of some factors influencing alpha-adrenoceptor feed-back at the sympathetic junction in the rat heart.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

6.  Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens.

Authors:  L L Iversen; S Z Langer
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

7.  Differences between the prejunctional effects of phenylephrine and clonidine in guinea-pig isolated atria.

Authors:  F Ledda; L Mantelli
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

8.  Experimental conditions required for the enhancement by alpha-adrenoceptor antagonists of noradrenaline release in the rabbit ear artery.

Authors:  W Auch-Schwelk; K Starke; A Steppeler
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

  8 in total
  2 in total

1.  Modulation of noradrenaline release by presynaptic alpha-2 and beta adrenoceptors in rat atria. Effect of pretreatment with clenbuterol.

Authors:  M G Kazanietz; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

2.  Influence of phorbol esters on stimulation-induced noradrenaline release and contractile force of isolated guinea-pig atria.

Authors:  H Brasch
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.